25.56
Artivion Inc Stock (AORT) Latest News
Artivion Inc. Reports Strong 2024 Earnings Amid Challenges - TipRanks
Artivion (AORT) Shares Drop After Weak Q4 2024 Results - GuruFocus.com
Artivion (AORT) Stock Trades Down, Here Is Why - Financial Content
Stifel cuts Artivion stock price target to $30 from $33, keeps Buy rating - Investing.com India
Artivion, Inc. (NYSE:AORT) Q4 2024 Earnings Call Transcript - Insider Monkey
Breaking Down Artivion: 4 Analysts Share Their Views - Benzinga India
Artivion stock price target cut to $32 at Needham amid sales hit By Investing.com - Investing.com South Africa
JMP maintains Artivion stock $33 target despite cyber incident By Investing.com - Investing.com South Africa
JMP maintains Artivion stock $33 target despite cyber incident - Investing.com
Artivion’s revenue increases 4% to USD 97.3M in Q4 2024 - Medical Buyer
Artivion Inc (AORT) Q4 2024 Earnings Call Highlights: Revenue Gr - GuruFocus.com
Artivion Inc (AORT) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Cyber Challenges - Yahoo Finance
Artivion, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Artivion Inc. Reports Strong 2024 Financial Results - TipRanks
Earnings call transcript: Artivion Q4 2024 misses revenue forecast, stock drops - Investing.com UK
Artivion Inc Reports Q4 2024 Earnings: EPS of $(0.39) Misses Est - GuruFocus.com
Artivion (AORT) Reports Break-Even Earnings for Q4 - Yahoo Finance
Artivion: Q4 Earnings Snapshot - The Washington Post
Artivion shares tumble on revenue miss and weak guidance By Investing.com - Investing.com South Africa
Artivion shares tumble on revenue miss and weak guidance - Investing.com India
Earnings Flash (AORT) ARTIVION INC. Posts Q4 Adjusted EPS $0.00, vs. FactSet Est of $0.04 - Marketscreener.com
Earnings Flash (AORT) ARTIVION INC. Reports Q4 Revenue $97.3M, vs. FactSet Est of $100.9M - Marketscreener.com
Artivion Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView
Artivion (NYSE:AORT) Misses Q4 Sales Targets - Yahoo Finance
Artivion (AORT) Q4 Earnings: What To Expect - The Globe and Mail
New York State Teachers Retirement System Reduces Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Earnings To Watch: Artivion Inc (AORT) Reports Q4 2024 Result - GuruFocus.com
Artivion Inc expected to post a loss of 6 cents a shareEarnings Preview - TradingView
Artivion (NYSE:AORT) Q3 Earnings: Leading The Medical Devices & SuppliesCardiology, Neurology, Vascular Pack - Investing.com Canada
Is Now An Opportune Moment To Examine Artivion, Inc. (NYSE:AORT)? - Simply Wall St
Artivion (AORT) Projected to Post Quarterly Earnings on Thursday - Defense World
$536.73 Bn Organ Preservation Solution Market Strategies and Opportunities to 2033: New R&D Center to Revolutionize Organ Preservation Techniques and Enhance Global Healthcare Solutions - GlobeNewswire Inc.
Cardiac Tissue Engineering Market 2025 Top Business Strategy, Growth Factors, Healthy CAGR with Segments & Forecast with Top 5 Key Players Analysis - The Globe and Mail
SG Americas Securities LLC Has $206,000 Stock Holdings in Artivion, Inc. (NYSE:AORT) - MarketBeat
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2024 Financial Results - Longview News-Journal
Wound Closure Market Size to Hit USD 26.63 Billion by 2032, Growing at a CAGR of 6.47% - GlobeNewswire Inc.
Artivion (AORT) Q4 Earnings Call: Strategic Growth Update & Financial Metrics RevealMark Your Calendar - StockTitan
SG Americas Securities LLC Sells 9,689 Shares of Artivion, Inc. (NYSE:AORT) - Defense World
Artivion, Inc. (NYSE:AORT) Shares Acquired by Calamos Advisors LLC - MarketBeat
Artivion (NYSE:AORT) Receives Buy Rating from Needham & Company LLC - MarketBeat
Needham & Company LLC Reiterates Buy Rating for Artivion (NYSE:AORT) - Defense World
Where Artivion Stands With Analysts - Benzinga
Oppenheimer maintains Artivion Outperform with $32 target - MSN
Oppenheimer maintains Artivion stock with $32 target By Investing.com - Investing.com Canada
Oppenheimer maintains Artivion stock with $32 target - Investing.com
Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 61st Society of Thoracic Surgery Annual Meeting - PR Newswire
Artivion, Inc. (NYSE:AORT) Holdings Raised by JPMorgan Chase & Co. - MarketBeat
JPMorgan Chase & Co. Has $2.61 Million Stock Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Is Artivion, Inc. (AORT) Among Billionaire Joseph Edelman’s Long-Term Stock Picks? - MSN
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):